NCT01668303

Brief Summary

The objective of the proposed study is to adapt and implement an efficacious adolescent substance abuse treatment, Multidimensional Family Therapy (MDFT), within the juvenile drug court service system. Additionally, the investigators will also examine the extent to which MDFT can enhance the effectiveness of existing juvenile drug court services in terms of decreasing drug use, delinquent behavior and arrests and improving school and vocational outcomes. The study design is a fully randomized controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2004

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

August 6, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 20, 2012

Completed
Last Updated

August 20, 2012

Status Verified

August 1, 2012

Enrollment Period

5.4 years

First QC Date

August 6, 2012

Last Update Submit

August 14, 2012

Conditions

Keywords

juvenile drug courtadolescentssubstance abusedelinquencyfamily therapymultidimensional family therapy

Outcome Measures

Primary Outcomes (9)

  • Graduation from juvenile drug court

    Status of drug court graduation (graduated from drug court or did not graduate from drug court)

    Collected once at 12 months from intake/baseline.

  • Change in substance use

    Personal Experiences with Chemicals Inventory

    Baseline at the begining of the study, and then at 6, 12, 18, and 24 months after baseline

  • Change in delinquency

    Self-report, parent report, and juvenile justice records: Self-report delinquency scale, Youth Self Report, Child Behavior Checklist; arrests and disposition from juvenile justice records.

    Baseline, and then at 6, 12, 18, and 24 months after baseline

  • Change in Mental health symptoms

    Youth and parent report: Child Behavior Checklist, Youth Self Report

    Baseline, 6, 12, 18 and 24 months after baseline

  • Change in Family functioning

    Youth and Parent Report: Family Environment Scales, Parental Stress Index, Behavior Affect Relationship Scales

    Baseline, 6, 14, 18, and 24 months after baseline

  • Length of treatment

    How many weeks of treatment received

    Collected once, at 12 months after baseline

  • Change in arrests

    Arrests will be extracted from juvenile justice records.

    12 months before intake through 24 months after intake

  • Change in substance use

    Measured by the Timeline Follow Back Method

    Intake, 6, 12, 18, 24 months after intake

  • Change in substance use

    Urinanalysis to detect drugs

    Intake, 6, 12, 18 and 24 months after intake

Study Arms (2)

Miami Juvenile Drug Court-MDFT

EXPERIMENTAL

Multidimensional family therapy (MDFT) is primarily a family-based approach (Liddle, 2002)which conducts individual sessions with the teen and parent\[s\] but not peer-group sessions.

Behavioral: Miami Juvenile Drug Court-MDFT

Miami Juvenile Drug Court -TAU

OTHER

The Treatment as Usual (TAU) condition is primarily a peer group-based and individual approach that uses cognitive-behavioral principles and interventions.

Behavioral: Miami Juvenile Drug Court -TAU

Interventions

MDFT assesses and intervenes in five domains: 1) Interventions with the adolescent, 2) interventions with the parent, 3) interventions to improve the parent-adolescent relationship, 4) interventions with other family members, and 5) interventions with external systems.

Miami Juvenile Drug Court-MDFT

Each client is provided with a primary outpatient counselor who develops a treatment plan to address long-range goals. Family members are included in an assessment and treatment planning session at the beginning of treatment, but no formal family therapy is provided. Group therapy topics include self-esteem enhancement, decision-making skills, stress/anger management, communication skills, health education, teen pregnancy prevention, and occupational/career planning.

Miami Juvenile Drug Court -TAU

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • (a) Substance abuse or dependence disorder requiring outpatient treatment, and (b)after consulting with his or her attorney, the youth and family voluntarily agrees to enter juvenile drug court.

You may not qualify if:

  • (a) Their current offense is the sale of drugs, a gun offense, a violent offense, or sexual battery,(b) their current offense is likely to merit commitment to a secure or locked juvenile justice facility or (c) they have severe mental illness or retardation according to their intake MJDC evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Here's Help Inc.

Miami, Florida, 33054, United States

Location

Jackson Memorial Hospital

Miami, Florida, 33136, United States

Location

University of Miami Miller School of Medicine

Miami, Florida, 33136, United States

Location

Juvenile Drug Court

Miami, Florida, 33142, United States

Location

Related Publications (1)

  • Dakof GA, Henderson CE, Rowe CL, Boustani M, Greenbaum PE, Wang W, Hawes S, Linares C, Liddle HA. A randomized clinical trial of family therapy in juvenile drug court. J Fam Psychol. 2015 Apr;29(2):232-41. doi: 10.1037/fam0000053. Epub 2015 Jan 26.

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Gayle A. Dakof, Ph.D.

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 6, 2012

First Posted

August 20, 2012

Study Start

June 1, 2004

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

August 20, 2012

Record last verified: 2012-08

Locations